LQDA Liquidia Technologies, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

LQDA [NASD]

Liquidia Technologies, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-2.26	Insider Own	0.60%	Shs Outstand	28.43M	Perf Week	-10.14%
Market Cap	298.49M	Forward P/E	-	EPS next Y	-2.06	Insider Trans	-	Shs Float	21.00M	Perf Month	-9.16%
Income	-48.60M	PEG	-	EPS next Q	-0.50	Inst Own	45.80%	Short Float	6.77%	Perf Quarter	29.17%
Sales	8.10M	P/S	36.85	EPS this Y	24.60%	Inst Trans	-1.91%	Short Ratio	4.30	Perf Half Y	82.35%
Book/sh	0.77	P/B	9.66	EPS next Y	10.40%	ROA	-81.50%	Target Price	-	Perf Year	-7.00%
Cash/sh	1.00	P/C	7.44	EPS next 5Y	-	ROE	-179.40%	52W Range	2.65 - 12.10	Perf YTD	74.04%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-88.30%	52W High	-38.51%	Beta	-
Dividend %	-	Quick Ratio	2.60	Sales past 5Y	-	Gross Margin	90.00%	52W Low	180.75%	ATR	1.01
Employees	64	Current Ratio	2.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	39.83	Volatility	10.26% 10.19%
Optionable	Yes	Debt/Eq	0.76	EPS Q/Q	39.40%	Profit Margin	-	Rel Volume	2.05	Prev Close	7.55
Shortable	Yes	LT Debt/Eq	0.43	Earnings	-	Payout	-	Avg Volume	330.30K	Price	7.44
Recom	1.70	SMA20	-17.57%	SMA50	-9.55%	SMA200	34.69%	Volume	676,464	Change	-1.46%

Nov-08-18

Resumed

Jefferies

Buy

Sep-05-18

Initiated

Wedbush

Outperform

$26

Aug-20-18

Initiated

Needham

Buy

$30

Aug-20-18

Initiated

Jefferies

Buy

$22

Jul-08-20 10:35PM	SHAREHOLDER ALERT: Halper Sadeh LLP Announces It is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm PR Newswire
Jul-02-20 04:01PM	Liquidia Announces Closing of Public Offering of Common Stock GlobeNewswire -5.92%
Jun-30-20 07:41AM	The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test Benzinga -21.09%
Jun-29-20 10:45PM	Liquidia to Host Conference Call to Provide Update on Recent Announcements GlobeNewswire
10:30PM	Liquidia Announces Pricing of Public Offering of Common Stock GlobeNewswire
04:05PM	Liquidia Announces Proposed Offering of Common Stock GlobeNewswire
04:01PM	Liquidia to Acquire RareGen, LLC, and Expand Presence in PAH GlobeNewswire
Jun-16-20 08:20AM	Is Liquidia Technologies (NASDAQ:LQDA) Using Debt In A Risky Way? Simply Wall St. +5.39%
Jun-12-20 07:09PM	Do Hedge Funds Love Liquidia Technologies, Inc. (LQDA)? Insider Monkey
Jun-05-20 03:30PM	Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents GlobeNewswire -20.08%
May-29-20 10:31AM	Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne Zacks
May-27-20 08:04PM	Liquidia to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-22-20 10:01AM	Why Liquidia Technologies (LQDA) Stock Might be a Great Pick? Zacks +5.50%
May-18-20 07:15AM	Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer GlobeNewswire +7.87%
May-11-20 04:01PM	Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire +9.59%
May-07-20 09:30AM	These 3 Biotech Stocks Have Massive Upside Potential, Says Wedbush TipRanks +9.81%
May-06-20 06:30PM	Liquidia to Report First Quarter 2020 Financial Results and Provide Corporate Update on May 11, 2020 GlobeNewswire -10.20%
Apr-30-20 07:30AM	Liquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension GlobeNewswire -11.70%
Apr-09-20 07:30AM	Liquidia to Present at the 19th Annual Needham Healthcare Conference GlobeNewswire
Apr-08-20 07:45AM	Liquidia Announces FDA Acceptance of New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension GlobeNewswire +17.07%
Mar-11-20 08:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Misses Revenue Estimates Zacks
07:00AM	Liquidia Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update GlobeNewswire
Mar-04-20 12:30PM	Will Liquidia Technologies, Inc. (LQDA) Report Negative Earnings Next Week? What You Should Know Zacks +15.10%
Feb-26-20 04:30PM	Liquidia to Report 2019 Financial Results and Provide Corporate Update on March 11, 2020 GlobeNewswire
04:30PM	Liquidia to Present at Cowen 40th Annual Health Care Conference GlobeNewswire
Jan-27-20 02:55PM	Liquidia seeks pivotal FDA approval for lead drug American City Business Journals -8.13%
08:00AM	Liquidia Submits New Drug Application for LIQ861 (treprostinil) inhalation powder to U.S. Food and Drug Administration for the Treatment of Pulmonary Arterial Hypertension (PAH) GlobeNewswire
Jan-24-20 09:00AM	Liquidia Announces Poster Presentation at the 14th Annual World Congress of the Pulmonary Vascular Research Institute (PVRI) GlobeNewswire -8.81%
Jan-15-20 07:29AM	Will Liquidia Continue to Surge Higher? Zacks +13.96%
Dec-26-19 02:55PM	Liquidia nets $22.4 million as it moves forward with lead drug American City Business Journals +43.47%
10:32AM	Liquidia Technologies stock soars after Wedbush says private placement gives company runway through Q4 2020 MarketWatch
Dec-24-19 08:30AM	Liquidia Technologies Announces $22.4 Million Private Placement GlobeNewswire +12.46%
Dec-20-19 06:21PM	Is Liquidia Technologies, Inc. (LQDA) A Good Stock To Buy? Insider Monkey
Nov-13-19 08:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Misses Revenue Estimates Zacks +8.45%
07:00AM	Liquidia Technologies Reports Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
06:00AM	Liquidia Technologies, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-19 08:00AM	Liquidia to Report Third Quarter 2019 Financial Results and Provide Corporate Update on November 13, 2019 GlobeNewswire -14.59%
Nov-01-19 08:00AM	Liquidia Technologies Appoints Industry Veteran Katie Rielly-Gauvin to Board of Directors GlobeNewswire +7.08%
Oct-23-19 10:33AM	Liquidia Technologies, Inc. (LQDA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks +7.43%
Oct-22-19 10:52AM	Is Liquidia Technologies (NASDAQ:LQDA) Using Too Much Debt? Simply Wall St.
Sep-25-19 04:05PM	Liquidia to Present at Cantor 2019 Global Healthcare Conference GlobeNewswire
Sep-12-19 04:05PM	Liquidia Technologies Appoints Industry Veteran Dr. Joanna Horobin to Board of Directors GlobeNewswire
Sep-03-19 07:00AM	Liquidia to Present at H.C. Wainwright Healthcare Conference GlobeNewswire -18.97%
Aug-27-19 02:44PM	Morrisville's Liquidia seeks partner as it prepares to launch new drug American City Business Journals -17.57%
Aug-08-19 04:05PM	Liquidia to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire +9.60%
07:00AM	Liquidia Technologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-02-19 09:00AM	Liquidia to Report Second Quarter 2019 Financial Results and Provide Corporate Update on August 8, 2019 GlobeNewswire -6.62%
Jul-24-19 01:01PM	Could Liquidia Technologies, Inc.'s (NASDAQ:LQDA) Investor Composition Influence The Stock Price? Simply Wall St.
Jun-28-19 08:35PM	Hedge Funds Have Never Been This Bullish On Liquidia Technologies, Inc. (LQDA) Insider Monkey
02:17PM	Behind Liquidia's new deal with GSK American City Business Journals
Jun-26-19 04:15PM	Liquidia and GSK Restructure Collaboration Agreement GlobeNewswire -5.01%
Jun-05-19 04:05PM	Liquidia Announces Clinical Update on INSPIRE; Targeting NDA Filing for LIQ861 in Late 2019 GlobeNewswire
Jun-03-19 08:30AM	Liquidia to Present at Jefferies Healthcare Conference GlobeNewswire
May-22-19 04:30PM	Liquidia Appoints Seasoned Biopharmaceutical Industry Executive Dr. Richard Katz as Chief Financial Officer GlobeNewswire
May-14-19 04:15PM	Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) International Conference 2019 GlobeNewswire
May-02-19 07:00AM	Liquidia Technologies Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire -8.57%
Apr-23-19 04:05PM	Liquidia Technologies to Report First Quarter 2019 Financial Results and Provide Corporate Update on May 2, 2019 GlobeNewswire
Apr-03-19 04:30PM	Liquidia Technologies Presents Phase 3 Trial Data for LIQ861 at the ISHLT 39th Annual Meeting & Scientific Sessions GlobeNewswire
Apr-02-19 08:00AM	Liquidia Technologies to Present at Needham Healthcare Conference GlobeNewswire
Mar-25-19 10:54AM	Liquidia Technologies Announces Closing of Offering of Common Stock GlobeNewswire
Mar-21-19 07:56AM	Liquidia Technologies Announces Pricing of Offering of Common Stock GlobeNewswire -18.55%
Mar-19-19 08:57AM	Morrisville company looks to Wall Street again American City Business Journals -13.82%
Mar-18-19 04:45PM	Liquidia Technologies Announces Proposed Offering of Common Stock GlobeNewswire +5.56%
Mar-11-19 07:00AM	Liquidias LIQ861 Meets Primary Endpoint in Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension GlobeNewswire
Feb-26-19 07:00AM	Liquidia Technologies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update GlobeNewswire -5.46%
Feb-13-19 04:30PM	Liquidia Technologies to Report 2018 Financial Results and Provide Corporate Update on February 26, 2019 GlobeNewswire
Jan-07-19 07:00AM	Liquidia Technologies Reports Positive Interim LIQ861 Safety Data on 109 Patients from Pivotal INSPIRE Trial GlobeNewswire
Dec-27-18 09:23AM	Stocks down in December for pharma firms in the Triangle American City Business Journals -9.62%
Nov-27-18 04:45PM	Liquidia Technologies Provides Leadership Update GlobeNewswire
02:04PM	Liquidia Technologies Inc (NASDAQ:LQDA): Time For A Financial Health Check Simply Wall St.
Nov-14-18 04:30PM	Liquidia Technologies Recipient of Best-in-Class Public Offering Award at Southeast BIO GlobeNewswire +14.65%
08:00AM	Liquidia Technologies to Present LIQ865 Phase 1a Data at ASRAs 17th Annual Pain Medicine Meeting GlobeNewswire
07:55AM	Analysis: Positioning to Benefit within Harvest Capital Credit, Zynga, Unique Fabricating, SJW Group, Liquidia Technologies, and Rave Restaurant Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-09-18 08:00AM	Liquidia Technologies to Present at Jefferies London Healthcare Conference GlobeNewswire
Nov-01-18 08:14AM	Liquidia Technologies refocuses efforts American City Business Journals
Oct-31-18 07:00AM	Liquidia Technologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire -12.55%
Oct-23-18 08:00AM	Liquidia Technologies to Provide Third Quarter 2018 Corporate Update on October 31, 2018 GlobeNewswire -7.82%
Sep-24-18 08:00AM	Liquidia Technologies Added to Russell 2000®, 3000® and Microcap® Indexes GlobeNewswire
Aug-20-18 03:45PM	Liquidia Well-Positioned With PRINT, Jefferies Says Benzinga +9.73%
Aug-09-18 08:00AM	Liquidia Technologies to Present at Wedbush PacGrow Healthcare Conference GlobeNewswire +9.66%
Jul-31-18 02:45PM	Liquidia closes IPO American City Business Journals
Jul-30-18 04:15PM	Liquidia Technologies Announces Closing of Initial Public Offering Business Wire
Jul-25-18 07:02PM	Liquidia Technologies Announces Pricing of Initial Public Offering Business Wire
Jul-21-18 09:03AM	The IPO Outlook For The Week: Tech & International Exposure Benzinga

Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of novel products utilizing its proprietary PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to enhance the safety, efficacy, and performance of a range of therapies. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that has completed Phase III clinical trial for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865 for the treatment of local post-operative pain that is in Phase II-enabling toxicology studies. It has collaboration agreements with GlaxoSmithKline plc and the University of North Carolina. Liquidia Technologies, Inc. was founded in 2004 and is headquartered in Morrisville, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Eshelman Ventures, LLC	10% Owner	Jul 02	Buy	8.00	1,875,000	15,000,000	7,034,744	Jul 02 07:31 PM
Maynor Benjamin	SVP, Research and Development	May 27	Option Exercise	2.69	4,754	12,788	11,735	May 28 04:30 PM
Maynor Benjamin	SVP, Research and Development	Apr 14	Option Exercise	1.85	6,132	11,344	10,300	Apr 16 04:30 PM
Eshelman Ventures, LLC	10% Owner	Apr 06	Buy	5.28	44,250	233,715	175,573	Apr 07 05:18 PM
Eshelman Ventures, LLC	10% Owner	Apr 03	Buy	4.85	35,000	169,740	131,323	Apr 07 05:18 PM
Eshelman Ventures, LLC	10% Owner	Apr 02	Buy	4.96	7,223	35,792	96,323	Apr 03 05:40 PM
Eshelman Ventures, LLC	10% Owner	Apr 01	Buy	4.89	45,000	220,122	89,100	Apr 03 05:40 PM
Eshelman Ventures, LLC	10% Owner	Mar 31	Buy	4.87	30,000	146,112	44,100	Apr 01 05:35 PM
Eshelman Ventures, LLC	10% Owner	Mar 30	Buy	4.76	14,100	67,106	14,100	Apr 01 05:35 PM
Canaan VIII LP	10% Owner	Dec 27	Buy	3.13	319,488	999,997	2,917,169	Jan 10 04:20 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience